During the quarter, Unichem Labs classified an expense of ₹58.26 crore as an exceptional item, which pertained to interest on a fine imposed by the European Commission. Adjusted for the exceptional item, Unichem Labs would have reported a net profit on a consolidated basis, higher than the same quarter last year.
Unichem Labs' revenue rose 14.2% year-on-year to ₹579 crore from ₹507 crore, while its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) grew by 19.2% to ₹66 crore from ₹55.3 crore last year.
Unichem Labs' EBITDA margin expanded by 50 basis points on a year-on-year basis to 11.4% from 10.9% during the base quarter.
Shares of Unichem Labs gained as much as 6% after the earnings announcement, currently trading 5.6% higher at ₹488.25. The stock has been an underperformer in 2025, having declined 33% so far during the year.
/images/ppid_59c68470-image-176285508663949616.webp)

/images/ppid_59c68470-image-176285003377957198.webp)
/images/ppid_59c68470-image-176285254030733914.webp)
/images/ppid_59c68470-image-176276753181985350.webp)
/images/ppid_59c68470-image-176278753106966487.webp)
/images/ppid_59c68470-image-176276761675870842.webp)
/images/ppid_59c68470-image-176278003591317577.webp)
/images/ppid_59c68470-image-176275004123785922.webp)
/images/ppid_59c68470-image-176283753359064091.webp)
/images/ppid_59c68470-image-176275272075257218.webp)
/images/ppid_59c68470-image-176259753536268969.webp)